(Q45757696)

15 December 2017

title

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study (English)

1 reference

15 December 2017

0 references

0 references

1 reference

1 reference

1 reference

Ikeda K

1

1 reference

15 December 2017

Saitoh S

2

1 reference

15 December 2017

Suzuki Y

3

1 reference

15 December 2017

Kobayashi M

4

1 reference

15 December 2017

Tsubota A

5

1 reference

15 December 2017

Fukuda M

6

1 reference

15 December 2017

Koida I

7

1 reference

15 December 2017

Arase Y

8

1 reference

15 December 2017

Chayama K

9

1 reference

15 December 2017

Murashima N

10

1 reference

15 December 2017

Kumada H

11

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

15 December 2017

published in

Cancer

1 reference

15 December 2017

volume

82

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

827-835

1 reference

15 December 2017

A case/control study of the association between primary liver cancer and hepatitis b infection in senegal

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980301%2982%3A5%3C827%3A%3AAID-CNCR5%3E3.0.CO%3B2-G

10.1002/(SICI)1097-0142(19980301)82:5<827::AID-CNCR5>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017